CDH2 and breast cancer: It is known that in breast cancer progression the loss of E-cadherin–based cell adhesion is an important factor in tumour invasiveness and that an over-expression of another adhesion molecule, the N-cadherin, is associated with an increased invasive potential of tumour cells[21-25].